Roundup: Artrya bags more market approvals for AI software after US FDA setback and more briefs

Must read

Artrya secures UK, EU approvals for Salix

Within a week, ASX-listed medtech company Artrya received both regulatory approvals from the European Union and the United Kingdom for its Salix Coronary Anatomy product.

The AI-powered software identifies and analyses arterial plaque to diagnose coronary artery disease. 

The recent certifications allow Artrya to market Salix in 28 EU member countries and in the UK, where it already has a four-year contract to supply 1,250 National Health Service Trust hospitals with the product.

These approvals also represent a win for the company after having a major setback in June when the US Food and Drug Administration rejected its initial 510(k) application for its software product.

Meanwhile, Salix is now geared for commercial rollouts in Australia and New Zealand after securing clearances over the past two years.

Global Health to deliver patient engagement, data solutions to upcoming The George Centre

Listed health technology firm Global Health has bagged a contract to deploy its patient engagement and data solutions to the soon-to-rise The George Centre by Acurio Health Group.

Global Health will deliver its MasterCare PAS, patient portal, data warehouse and e-switch integration engine to The George Centre, which construction is expected to be completed later this year. The health and wellness hub is envisioned to be one of the largest private maternity and paediatric hospitals in New South Wales.

Orion Health appoints new clinical director

Orion Health has named a former Southern Cross Healthcare director as its new clinical director for New Zealand and Australia.

Carey Campbell was the director of Nursing at Southern Cross Healthcare, holding the position since 2008. She was the clinical lead and product owner for the partnership between Orion Health and Southern Cross Healthcare, which saw the implementation of EMRs across 16 Southern Cross hospitals in the country.

She also previously held a number of leadership roles at the former Waikato District Health Board. 

In her new role, Campbell will engage and collaborate with customers and local communities as their advocate. 

“We know the expertise Carey brings from her time at Southern Cross Healthcare and Waikato DHB puts her in an excellent position to hit the ground running at Orion Health,” Orion Health CEO Brad Porter said about Campbell’s appointment.

RMIT researchers working on mobile thermal imaging tool for screening chronic wounds

A research team from RMIT University and Bolton Clarke Research Institute are working to get their thermal imaging tool for screening chronic wounds to mobile devices.

This comes after they successfully demonstrated a much quicker detection of chronic leg wounds using AI-powered technology in a recent clinical study.

“Our new work that identifies chronic leg wounds during the first visit is a world-first achievement,” said lead researcher Dinesh Kumar, who is also a professor at the RMIT School of Engineering.

While thermal imaging has seen frequent use for detecting chronic wounds, the team’s AI system can make “significantly earlier” detection than existing approaches.

“Our innovation is not sensitive to changes in ambient temperature and light, so it is effective for nurses to use during their regular visits to people’s homes,”  co-researcher Dr Quoc Cuong Ngo explained.

The research team is now proceeding to work on a mobile version of their thermal imaging solution after receiving funding from the federal government’s Medical Research Future Fund.

They are also looking to assess whether their AI technology can also predict the healing of diabetes-related foot ulcers.

Source link

- Advertisement -spot_img

More articles


Please enter your comment!
Please enter your name here

- Advertisement -spot_img

Latest article